APO Research
Talk to an analyst

APO RESEARCH · REPORT

Developmental and Reproductive Toxicology (DART) Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Developmental and Reproductive Toxicology (DART) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026196 pages

Choose your research edition.

Industry ResearchDevelopmental and Reproductive Toxicology (DART) Services Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Developmental and Reproductive Toxicology (DART) Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Developmental and Reproductive Toxicology (DART) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Developmental and Reproductive Toxicology (DART) Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Developmental and Reproductive Toxicology (DART) Services Market Analysis and Forecast 2026-2032174 pages · $4,950 USD

Market perspective

The global Developmental and Reproductive Toxicology (DART) Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Developmental and Reproductive Toxicology (DART) Services include AnaPath Services, Frontage, WuXi AppTec, Creative Animodel, Pharmaron, Labcorp, RCC, Creative Biolabs and IITRI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Developmental and Reproductive Toxicology (DART) Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Developmental and Reproductive Toxicology (DART) Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Developmental and Reproductive Toxicology (DART) Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Developmental and Reproductive Toxicology (DART) Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Developmental and Reproductive Toxicology (DART) Services Segment by Company

AnaPath Services

Frontage

WuXi AppTec

Creative Animodel

Pharmaron

Labcorp

RCC

Creative Biolabs

IITRI

Syngene

JOINN

Inotiv

Accelera

Charles River

Developmental and Reproductive Toxicology (DART) Services Segment by Type

Fertility and Early Embryonic Development (FEED) study

Embryofetal Development (EFD) study

Pre- and Post-natal (PPND) study

Others

Developmental and Reproductive Toxicology (DART) Services Segment by Application

Biotechnology

Academic Research

Others

Developmental and Reproductive Toxicology (DART) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Developmental and Reproductive Toxicology (DART) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Developmental and Reproductive Toxicology (DART) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Developmental and Reproductive Toxicology (DART) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Developmental and Reproductive Toxicology (DART) Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Developmental and Reproductive Toxicology (DART) Services industry.

Chapter 3: Detailed analysis of Developmental and Reproductive Toxicology (DART) Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Developmental and Reproductive Toxicology (DART) Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Fertility and Early Embryonic Development (FEED) study Table 3. Key Players of Embryofetal Development (EFD) study Table 4. Key Players of Pre- and Post-natal (PPND) study Table 3. Key Players of Others Table 4. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biotechnology Table 6. Key Players of Academic Research Table 7. Key Players of Others Table 8. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Region (2021-2026) Table 11. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Region (2027-2032) Table 13. Developmental and Reproductive Toxicology (DART) Services Industry Trends Table 14. Developmental and Reproductive Toxicology (DART) Services Industry Drivers Table 15. Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges Table 16. Developmental and Reproductive Toxicology (DART) Services Industry Restraints Table 17. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Company (2021-2026) Table 19. Global Developmental and Reproductive Toxicology (DART) Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Developmental and Reproductive Toxicology (DART) Services Key Company Head Office and Area Served Table 21. Global Developmental and Reproductive Toxicology (DART) Services Company, Product Type & Application Table 22. Global Developmental and Reproductive Toxicology (DART) Services Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Developmental and Reproductive Toxicology (DART) Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2021-2026) Table 29. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2027-2032) Table 30. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2021-2026) Table 34. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2027-2032) Table 35. AnaPath Services Company Information Table 36. AnaPath Services Business Overview Table 37. AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 39. AnaPath Services Recent Development Table 40. Frontage Company Information Table 41. Frontage Business Overview Table 42. Frontage Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 44. Frontage Recent Development Table 45. WuXi AppTec Company Information Table 46. WuXi AppTec Business Overview Table 47. WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 49. WuXi AppTec Recent Development Table 50. Creative Animodel Company Information Table 51. Creative Animodel Business Overview Table 52. Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 54. Creative Animodel Recent Development Table 55. Pharmaron Company Information Table 56. Pharmaron Business Overview Table 57. Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 59. Pharmaron Recent Development Table 60. Labcorp Company Information Table 61. Labcorp Business Overview Table 62. Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 64. Labcorp Recent Development Table 65. RCC Company Information Table 66. RCC Business Overview Table 67. RCC Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 69. RCC Recent Development Table 70. Creative Biolabs Company Information Table 71. Creative Biolabs Business Overview Table 72. Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 74. Creative Biolabs Recent Development Table 75. IITRI Company Information Table 76. IITRI Business Overview Table 77. IITRI Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 79. IITRI Recent Development Table 80. Syngene Company Information Table 81. Syngene Business Overview Table 82. Syngene Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 84. Syngene Recent Development Table 85. JOINN Company Information Table 86. JOINN Business Overview Table 87. JOINN Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 89. JOINN Recent Development Table 90. Inotiv Company Information Table 91. Inotiv Business Overview Table 92. Inotiv Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 94. Inotiv Recent Development Table 95. Accelera Company Information Table 96. Accelera Business Overview Table 97. Accelera Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 99. Accelera Recent Development Table 100. Charles River Company Information Table 101. Charles River Business Overview Table 102. Charles River Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 104. Charles River Recent Development Table 105. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026) Table 111. North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032) Table 112. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026) Table 118. Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032) Table 119. China Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026) & (US$ Million) Table 120. China Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032) & (US$ Million) Table 121. China Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026) & (US$ Million) Table 122. China Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026) Table 129. Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Developmental and Reproductive Toxicology (DART) Services Product Image Figure 2. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Type: 2025 VS 2032 Figure 4. Fertility and Early Embryonic Development (FEED) study Image Figure 5. Embryofetal Development (EFD) study Image Figure 6. Pre- and Post-natal (PPND) study Image Figure 7. Others Image Figure 8. Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Application: 2025 VS 2032 Figure 10. Biotechnology Image Figure 11. Academic Research Image Figure 12. Others Image Figure 13. Global Developmental and Reproductive Toxicology (DART) Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 15. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Developmental and Reproductive Toxicology (DART) Services Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Developmental and Reproductive Toxicology (DART) Services Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Type (2021-2032) Figure 22. Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Application (2021-2032) Figure 24. North America Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 25. North America Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032) Figure 26. North America Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032) Figure 27. North America Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032) Figure 28. United States Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 29. Canada Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032) Figure 33. Europe Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032) Figure 34. Europe Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032) Figure 35. Germany Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 36. France Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 38. Italy Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 39. Russia Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 41. China Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 42. China Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032) Figure 43. China Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032) Figure 44. Asia Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 45. Asia Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032) Figure 46. Asia Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032) Figure 47. Asia Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032) Figure 48. Japan Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 52. India Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 53. Australia Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032) Figure 58. Brazil Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 63. UAE Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 65. Chile Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Fertility and Early Embryonic Development (FEED) study
  • Embryofetal Development (EFD) study
  • Pre- and Post-natal (PPND) study
  • Others
Applications
  • Biotechnology
  • Academic Research
  • Others
Companies covered
  • AnaPath Services
  • Frontage
  • WuXi AppTec
  • Creative Animodel
  • Pharmaron
  • Labcorp
  • RCC
  • Creative Biolabs
  • IITRI
  • Syngene
  • JOINN
  • Inotiv
  • Accelera
  • Charles River

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Fertility and Early Embryonic Development (FEED) study
  5. 1.2.3 Embryofetal Development (EFD) study
  6. 1.2.4 Pre- and Post-natal (PPND) study
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Biotechnology
  11. 1.3.3 Academic Research
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Developmental and Reproductive Toxicology (DART) Services Growth Trends by Region
  15. 1.5.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2021-2026)
  17. 1.5.3 Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Developmental and Reproductive Toxicology (DART) Services Market Dynamics
  1. 2.1 Developmental and Reproductive Toxicology (DART) Services Industry Trends
  2. 2.2 Developmental and Reproductive Toxicology (DART) Services Industry Drivers
  3. 2.3 Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges
  4. 2.4 Developmental and Reproductive Toxicology (DART) Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Company (2021-2026)
  2. 3.2 Global Developmental and Reproductive Toxicology (DART) Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Developmental and Reproductive Toxicology (DART) Services Key Company Head office and Area Served
  4. 3.4 Global Developmental and Reproductive Toxicology (DART) Services Company, Product Type & Application
  5. 3.5 Global Developmental and Reproductive Toxicology (DART) Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Developmental and Reproductive Toxicology (DART) Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Developmental and Reproductive Toxicology (DART) Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Developmental and Reproductive Toxicology (DART) Services Tier 1, Tier 2, and Tier 3
4 Developmental and Reproductive Toxicology (DART) Services Market by Type
  1. 4.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2032)
  3. 4.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size Share by Type (2021-2032)
5 Developmental and Reproductive Toxicology (DART) Services Market by Application
  1. 5.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2032)
  3. 5.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AnaPath Services
  2. 6.1.1 AnaPath Services Company Information
  3. 6.1.2 AnaPath Services Business Overview
  4. 6.1.3 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  6. 6.1.5 AnaPath Services Recent Developments
  7. 6.2 Frontage
  8. 6.2.1 Frontage Company Information
  9. 6.2.2 Frontage Business Overview
  10. 6.2.3 Frontage Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  12. 6.2.5 Frontage Recent Developments
  13. 6.3 WuXi AppTec
  14. 6.3.1 WuXi AppTec Company Information
  15. 6.3.2 WuXi AppTec Business Overview
  16. 6.3.3 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  18. 6.3.5 WuXi AppTec Recent Developments
  19. 6.4 Creative Animodel
  20. 6.4.1 Creative Animodel Company Information
  21. 6.4.2 Creative Animodel Business Overview
  22. 6.4.3 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  24. 6.4.5 Creative Animodel Recent Developments
  25. 6.5 Pharmaron
  26. 6.5.1 Pharmaron Company Information
  27. 6.5.2 Pharmaron Business Overview
  28. 6.5.3 Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  30. 6.5.5 Pharmaron Recent Developments
  31. 6.6 Labcorp
  32. 6.6.1 Labcorp Company Information
  33. 6.6.2 Labcorp Business Overview
  34. 6.6.3 Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  36. 6.6.5 Labcorp Recent Developments
  37. 6.7 RCC
  38. 6.7.1 RCC Company Information
  39. 6.7.2 RCC Business Overview
  40. 6.7.3 RCC Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  42. 6.7.5 RCC Recent Developments
  43. 6.8 Creative Biolabs
  44. 6.8.1 Creative Biolabs Company Information
  45. 6.8.2 Creative Biolabs Business Overview
  46. 6.8.3 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  48. 6.8.5 Creative Biolabs Recent Developments
  49. 6.9 IITRI
  50. 6.9.1 IITRI Company Information
  51. 6.9.2 IITRI Business Overview
  52. 6.9.3 IITRI Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  54. 6.9.5 IITRI Recent Developments
  55. 6.10 Syngene
  56. 6.10.1 Syngene Company Information
  57. 6.10.2 Syngene Business Overview
  58. 6.10.3 Syngene Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  60. 6.10.5 Syngene Recent Developments
  61. 6.11 JOINN
  62. 6.11.1 JOINN Company Information
  63. 6.11.2 JOINN Business Overview
  64. 6.11.3 JOINN Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  66. 6.11.5 JOINN Recent Developments
  67. 6.12 Inotiv
  68. 6.12.1 Inotiv Company Information
  69. 6.12.2 Inotiv Business Overview
  70. 6.12.3 Inotiv Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  72. 6.12.5 Inotiv Recent Developments
  73. 6.13 Accelera
  74. 6.13.1 Accelera Company Information
  75. 6.13.2 Accelera Business Overview
  76. 6.13.3 Accelera Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  78. 6.13.5 Accelera Recent Developments
  79. 6.14 Charles River
  80. 6.14.1 Charles River Company Information
  81. 6.14.2 Charles River Business Overview
  82. 6.14.3 Charles River Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  84. 6.14.5 Charles River Recent Developments
7 North America
  1. 7.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
  2. 7.2 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Type
  3. 7.2.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032)
  6. 7.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Application
  7. 7.3.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032)
  10. 7.4 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country
  11. 7.4.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
  2. 8.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Type
  3. 8.2.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032)
  6. 8.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Application
  7. 8.3.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032)
  10. 8.4 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country
  11. 8.4.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
  2. 9.2 China Developmental and Reproductive Toxicology (DART) Services Market Size by Type
  3. 9.2.1 China Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026)
  4. 9.2.2 China Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032)
  5. 9.2.3 China Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032)
  6. 9.3 China Developmental and Reproductive Toxicology (DART) Services Market Size by Application
  7. 9.3.1 China Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026)
  8. 9.3.2 China Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032)
  9. 9.3.3 China Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
  2. 10.2 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Type
  3. 10.2.1 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032)
  6. 10.3 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Application
  7. 10.3.1 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032)
  10. 10.4 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country
  11. 10.4.1 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst